Rihab Hassoun-Barhamji1, Tiphaine Raia Barjat2, Céline Chauleur2. 1. Département de Médecine Générale de la Faculté de Saint-Étienne Jacques Lisfranc, Saint-Étienne, France. 2. Département d'Obstétrique et Gynécologie, CHU Saint-Étienne Hôpital Nord, Saint-Priest-en-Jarez, France - EA 3065 Groupe de Recherche sur la Thrombose, Université Jean Monnet, Saint-Étienne France.
Abstract
OBJECTIVE: Non-steroidal anti-inflammatory drugs (NSAIDs) are contraindicated in pregnancy because of the many foetal-maternal complications they can induce. Yet, NSAIDs can be massively found in family medicine cabinets and they are over-the-counter drugs for most of them. Because of the actual trend of empowerment and public authorities encouraging self-medication, NSAIDs might be used. Our aim was to assess pregnant women's knowledge of NSAIDs. STUDY DESIGN: A descriptive study, through the distribution of 330 questionnaires to all pregnant women consulting at the Teaching hospital of Saint-Etienne, during a week, from February 11th, 2014 to 19th, 2014. RESULTS: The answering rate was 96.4%. Around 46% of pregnant women declared self-medicating. More than 1 in 3 women considered NSAIDs without danger starting from their 6th month of pregnancy. Eighty-six percent of women recognized ibuprofen as belonging to NSAISs. However, 1 in 2 women didn't consider Rhinadvil® (ibuprofene/pseudoephedrine) as such and approximately 40% for Aspegic® (lysine acetylsalicylate) and Aspirin® (acetylsalicylic acid). Danger's perception varied according to the galenic and the trade name: 60% of them thought that Rhinadvil® was without risks and around 1 in 2 women thought the same for Aspirin® and Aspegic®. Eighty-six per cent of women recognized ibuprofen as belonging to NSAIDs. However, 1 in 2 women didn't consider Rhinadvil® as such and approximately 40% for Apegic® and Aspirin®. CONCLUSION: Pregnant women's knowledge of NSAIDs is not satisfactory. They are not aware of their danger and do not know how to recognize them. Yet, self-medication is rising and its accessibility is made easier. A work on prevention and information is therefore essential.
OBJECTIVE: Non-steroidal anti-inflammatory drugs (NSAIDs) are contraindicated in pregnancy because of the many foetal-maternal complications they can induce. Yet, NSAIDs can be massively found in family medicine cabinets and they are over-the-counter drugs for most of them. Because of the actual trend of empowerment and public authorities encouraging self-medication, NSAIDs might be used. Our aim was to assess pregnant women's knowledge of NSAIDs. STUDY DESIGN: A descriptive study, through the distribution of 330 questionnaires to all pregnant women consulting at the Teaching hospital of Saint-Etienne, during a week, from February 11th, 2014 to 19th, 2014. RESULTS: The answering rate was 96.4%. Around 46% of pregnant women declared self-medicating. More than 1 in 3 women considered NSAIDs without danger starting from their 6th month of pregnancy. Eighty-six percent of women recognized ibuprofen as belonging to NSAISs. However, 1 in 2 women didn't consider Rhinadvil® (ibuprofene/pseudoephedrine) as such and approximately 40% for Aspegic® (lysine acetylsalicylate) and Aspirin® (acetylsalicylic acid). Danger's perception varied according to the galenic and the trade name: 60% of them thought that Rhinadvil® was without risks and around 1 in 2 women thought the same for Aspirin® and Aspegic®. Eighty-six per cent of women recognized ibuprofen as belonging to NSAIDs. However, 1 in 2 women didn't consider Rhinadvil® as such and approximately 40% for Apegic® and Aspirin®. CONCLUSION: Pregnant women's knowledge of NSAIDs is not satisfactory. They are not aware of their danger and do not know how to recognize them. Yet, self-medication is rising and its accessibility is made easier. A work on prevention and information is therefore essential.
Authors: Millissia Ben Maamar; Laurianne Lesné; Kristin Hennig; Christèle Desdoits-Lethimonier; Karen R Kilcoyne; Isabelle Coiffec; Antoine D Rolland; Cécile Chevrier; David M Kristensen; Vincent Lavoué; Jean-Philippe Antignac; Bruno Le Bizec; Nathalie Dejucq-Rainsford; Rod T Mitchell; Séverine Mazaud-Guittot; Bernard Jégou Journal: Sci Rep Date: 2017-03-10 Impact factor: 4.379